Cryopreservation of human hematopoietic stem and progenitor cells loaded with trehalose: Transient permeabilization via the adenosine triphosphate-dependent P2Z receptor channel

Cell Preservation Technology

Volumn 3, Issue 4, 2005, Pages 212-222

  Buchanan, Sandhya S ^a   Menze, Michael A ^b   Hand, Steven C ^b   Pyatt, David W ^c   Carpenter, John F ^a,d  

^a UNIVERSITY OF COLORADO   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c LLP   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CRYOPROTECTIVE AGENT; DIMETHYL SULFOXIDE; DISACCHARIDE; GLUCOSE; PURINE P2X7 RECEPTOR; TREHALOSE;

ARTICLE; CELL ACTIVATION; CELL DAMAGE; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; CRYOPRESERVATION; ENVIRONMENTAL TEMPERATURE; FREEZE THAWING; FREEZING; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

EID: 30344443048     PISSN: 1538344X     EISSN: None     Source Type: Journal    
DOI: 10.1089/cpt.2005.3.212     Document Type: Article

References (40)

1. Voermans C, van Hennik PB, van Der Schoot CE. Homing of human hematopoietic stem and progenitor cells: New insights, new challenges? J Hematother Stem Cell Res. 2001;10:725-738.
2. Woods E, Liu J, Derrow CW, et al. Osmometric and permeability characteristics of human placental/umbilical cord blood CD34+ cells and their application to cryopreservation. J Hematother Stem Cell Res 2000;9:161-173.
3. Beaujean F, Bourhis JH, Bayle CH, et al. Successful cryopreservation of purified autologous CD34+ cells: Influence of freezing parameters on cell recovery and engraftment. Bone Marrow Transplant 1998;22:1091-1096.
4. Shpall E, LeMaistre CF, Holland K, et al. A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. Blood 1997;90:4313-4320.
5. Davis J, Rowley S, Braine H, et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990;75:781-786.
6. Stroncek D, Fautsch SK, Lasky LC, et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991;31:521-526.
7. Halle P, Tournilhac O, Knopinska-Posluszny W, et al. Uncontrolled-rate freezing and storage at -80°C, with only 3.5% DMSO in cryoprotective solution for 108 autologous peripheral blood progenitor cell transplantations. Transfusion 2001;41:667-673.
8. Massimo M, Fortunato M, Giuseppe M, et al. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologica 1996;81:59-61.
9. Carral A, de la Rubia J, Martin G, et al. Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies. Leuk Res 2003;27:5-12.
10. Guo N, Puhlev I, Brown DR, et al. Trehalose expression confers desiccation tolerance on human cells. Nat Biotechnol 2000;18:168-171.
11. Beattie GM, Crowe JH, Lopez AD, et al. Trehalose: A cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes 1997;46:519-523.
12. Oliver AE, Jamil K, Crowe JH, et al. Loading human mesenchymal stem cells with trehalose by fluid-phase endocytosis. Cell Preservation Technol 2005;2:35-49.
13. Russo M, Bayley H, Toner M. Reversible permeabilization of plasma membranes with an engineered switchable pore. Nat Biotechnol 1997;15:278-282.
14. Eroglu A, Russo MJ, Bieganski R, et al. Intracellular trehalose improves the survival of cryopreserved mammalian cells. Nat Biotechnol 2000;18:163-167.
15. Buchanan SS, Gross SA, Acker, JP, et al. Cryopreservation of stem cells using trehalose: Evaluation of the method using a human hematopoietic cell line. Stem Cells Development 2004;13:295-305.
16. Gordon JL. Extracellular ATP: Effects, sources and fate. Biochem J 1986;233:309-319.
17. Steinberg TH, Silverstein SC. ATP permeabilization of the plasma membrane. Methods Cell Biol 1989;31:45-61.
18. Surprenant A, Rassendren R, Kawashima E, et al. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996;272:735-738.
19. Collo G, Neidhart S, Kawashima E, et al. Tissue distribution of the P2X7 receptor. Neuropharmacol 1997;36:1277-1283.
20. Coutinho-Silva R, Anastficio Alves L, Savino W, et al. A cation non-selective channel induced by extracellular ATP in macrophages and phagocytic cells of the thymic reticulum. Biochim Biophys Acta 1996;1278:125-130.
21. Nihei OK, Savino, Wilson and Alves, Luiz Anastacio. Procedures to characterize and study P2Z/P2X7 purinoceptor: Flow cytometry as a promising practical, reliable tool. Mem Inst Oswaldo Cruz 2000;95:415-428.
22. Smart ML, Gu B, Panchal RG, et al. P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J Biol Chem 2003;278:8853-8860.
23. Menze MA, Clavenna M, Hand SC. Depression of cell metabolism and proliferation by membrane-permeable and -impermeable modulators: Role for AMP-to-ATP ratio. Am J Physiol (Regul Integr Comp Physiol) 2005;288:R501-R510.
24. Hand SC, Menze M. A preservation of eukaryotic cells. 2004. U.S. Pat. App. No. 10/965,039.
25. Di Virgilio F. The P2Z purinoceptor: An intriguing role in immunity, inflammation and cell death. Immunol Today. 1995;16:524-528.
26. Di Virgilio F, Chiozzi P, Ferrari D, et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001;97:587-600.
27. Suh B-C, Kim J-S, Namgung U, et al. P2X7 Nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils. J Immunol 2001;166:6754-6763.
28. Kitamura T, Tange T, Terasawa T, et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 1989;140:323-334.
29. Crowe JH, Panek AD, Crowe LM, et al. Trehalose transport in yeast cells. Biochem Int 1991;24:721-730.
30. De Araujo PS, Panek AC, Crowe JH, et al. Trehalose-transporting membrane vesicles from yeasts. Biochem Int 1991;24:731-737.
31. Eleutherio EC, Araujo PS, Panek AD. Role of the trehalose carrier in dehydration resistance of Saccharomyces cerevisiae. Biochim Biophys Acta 1993;1156:263-266.
32. Cuber R, Eleutherio EC, Pereira MD, et al. The role of the trehalose transporter during germination. Biochim Biophys Acta 1997;1330:165-171.
33. Redelman D. Flow cytometric analyses of cell phenotypes. In: Stewart CC, Nicholson, JKA, eds. Immunophenotyping. 1st ed. New York: Wiley-Liss, 2000:49-82.
34. Solini A, Chiozzi P, Morelli A, et al. Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci 1999;112:297-305.
35. Greig AVH, Linge C, Cambrey A, et al. Purinergic receptors are part of a signaling system for keratinocyte proliferation, differentiation, and apoptosis in human fetal epidermis. J Invest Dermatol 2003;121:1145-1149.
36. El-Moatassim C, Dornand J, Mani JC. Extracellular ATP and cell signalling. Biochim Biophys Acta 1992;1134:31-15.
37. Cario-Toumaniantz C, Loirand G, Ladoux A, et al. P2X7 receptor activation-induced contraction and lysis in human saphenous vein smooth muscle. Circ Res 1998;83:196-203.
38. Deuchars SA, Atkinson L, Brooke RE, et al. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci 2001;21:7143-7152.
39. Li Q, Luo X, Zeng W, et al. Cell-specific behavior of P2X7 receptors in mouse parotid acinar and duct cells. J Biol Chem 2003;278:47554-47561.
40. Michel A, Chessell IP, Hibell AD, et al. Identification and characterization of an endogenous P2X7 (P2Z) receptor in CHO-K1 cells. Br J Pharmacol 1998;125:1194-1201.